首页 >
法规速递
-
关于公开征求《化学仿制药参比制剂目录（第七十二批）》（征求意见稿）意见的通知-2023/7/4
2023-07-05查看详情 > -
国家药监局药审中心关于发布《抗肿瘤药物说明书安全性信息撰写技术指导原则》的通告（2024年第3号）-2024/1/16
2024-01-19查看详情 > -
Document: Agenda of the CHMP meeting 27-30 January 2025-2025/1/27
2025-02-05查看详情 > -
Page: Nitrosamine impurities in specific medicines-2025/2/28
2025-03-03查看详情 > -
Document: Medicine shortage communication (MSC): Mimpara (cinacalcet)-2025/4/7
2025-04-08查看详情 > -
Document: EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2025-2026-2025/5/16
2025-05-19查看详情 > -
Document: Minutes of the CVMP meeting 5-7 November 2024-2025/6/25
2025-06-26查看详情 > -
Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (20 June 2025 - 24 July 2025)-2025/7/28
2025-07-29查看详情 > -
Document: Network Portfolio Roadmap-2025/9/15
2025-09-16查看详情 > -
关于公开征求《中药注射剂上市后研究和评价基本技术要求（征求意见稿）》和《中药注射剂上市后研究和评价申报资料要求（征求意见稿）》意见的通知-2025/10/17
2025-10-20查看详情 >
